Skip to content

About Us
Our Science
Media
Pipeline
- Overview
- AWARE-1
- BRACELET-1
- GOBLET
Investors
- Overview
- News
- Events
- Stock Information
- Filings
- Corporate Governance
- FAQs
Careers
Contact

About Us
Our Science
Media
Pipeline
- Overview
- AWARE-1
- BRACELET-1
- GOBLET
Investors
- Overview
- News
- Events
- Stock Information
- Filings
- Corporate Governance
- FAQs
Careers
Contact

About Us
Our Science
Media
Pipeline
- Overview
- AWARE-1
- BRACELET-1
- GOBLET
Investors
- Overview
- News
- Events
- Stock Information
- Filings
- Corporate Governance
- FAQs
Careers
Contact

About Us
Our Science
Media
Pipeline
- Overview
- AWARE-1
- BRACELET-1
- GOBLET
Investors
- Overview
- News
- Events
- Stock Information
- Filings
- Corporate Governance
- FAQs
Careers
Contact

News

Select Year
Clinical Trials
Search …

October 1, 2013

Oncolytics Biotech Inc. Collaborators to Present Positive Clinical Trial Data at the 15th Annual World Conference on Lung Cancer

September 9, 2013

Oncolytics Biotech® Inc. Announces Positive Final Tumour Response Data for U.S. Phase 2 Study of REOLYSIN® in Squamous Cell Lung Cancer

September 9, 2013

Media Advisory – Oncolytics Biotech® Inc. Announces Participation in Upcoming Conferences

August 13, 2013

Media Advisory – Oncolytics Biotech® Inc. to Present at the 2013 Wedbush PacGrow Life Sciences Management Access Conference

June 4, 2013

Oncolytics Biotech® Inc. to Present at 2013 Jefferies Global Healthcare Conference

May 22, 2013

Oncolytics Biotech® Inc. Meets Primary Endpoint for First Stage of U.S. Phase 2 Metastatic Melanoma Trial

May 14, 2013

Media Advisory – Oncolytics Biotech® Inc. to Present at Bank of America Merrill Lynch Health Care Conference

May 10, 2013

Oncolytics Biotech® Inc. Announces Director Election Results from its Annual and Special Meeting of Shareholders

May 9, 2013

Oncolytics Biotech® Inc. Announces First Quarter 2013 Results

May 6, 2013

Oncolytics Biotech® Inc. Announces Details of 2013 Annual and Special Meeting of Shareholders

Page 44 of 69

Investor Relations Contact

Jon Patton
Director of Investor Relations & Communication
Email: jpatton@oncolytics.ca

Email Alerts Sign-Up

Email

I accept the Privacy Policy

Loading...

4350 Executive Drive
Suite 325
San Diego, CA 92121
info@oncolyticsbiotech.com

Company

About Us
Leadership
Scientific Advisors
Careers
Contact

Science

Our Science
Pipeline
Publications

Investors

Overview
News
Events
Stock Information
Filings
Corporate Governance
FAQs

Privacy Policy Accessibility Cookie Policy Disclaimer Sitemap Manage Consent

Copyright © 2025 Oncolytics Biotech Inc.